Health Catalyst
HCAT
145 hedge funds and large institutions have $154M invested in Health Catalyst in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 33 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 38
3% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 33
0% more funds holding
Funds holding: 145 → 145 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.88% less ownership
Funds ownership: 77.81% → 76.93% (-0.88%)
24% less capital invested
Capital invested by funds: $204M → $154M (-$49.9M)
69% less call options, than puts
Call options by funds: $283K | Put options by funds: $913K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.23M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.13M |
| 3 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$2.11M |
| 4 |
PVM
Palogic Value Management
Dallas,
Texas
|
+$1.24M |
| 5 |
AE
AMH Equity
Great Neck,
New York
|
+$797K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$7.47M |
| 2 |
Primecap Management
Pasadena,
California
|
-$2.11M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$1.79M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.17M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.06M |
HCAT Hedge Fund Activity: Q3 2025 in Review
145 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2025, worth a combined $154M — down 24% from $204M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new HCAT positions and 33 closed out — a net gain of 1 holder — while 42 added to existing stakes and 38 trimmed.
The largest buyer was Millennium Management, adding an estimated $5.23M. The largest seller was Portolan Capital Management, exiting entirely with an estimated $7.47M sold.
- 145 institutional investors held Health Catalyst (HCAT) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $154M of Health Catalyst stock for Q3 2025, down 24% quarter-over-quarter.
- 34 funds opened new Health Catalyst positions in Q3 2025 and 33 closed out, a net change of +1 holder.
- The largest Health Catalyst buyer in Q3 2025 was Millennium Management, an estimated $5.23M added.
- The largest Health Catalyst seller in Q3 2025 was Portolan Capital Management, an estimated $7.47M sold.
Based on aggregated 13F filings for Q3 2025.